With people of minority background and those with obesity and diabetes most at risk for severe cases of COVID-19, the National Institute of Diabetes and Digestive and Kidney Diseases is leading in the research behind why that is. Director Dr. Griffin Rodgers, who contributed to the first effective therapy for sickle cell anemia, updates HealthCast on the institute’s work to lessen the effects of COVID-19 on its research community, as well as other top research and data initiatives at the institution.
HealthCast
Season 2
Episode 17
21m listen
How One NIH Institute is Combating COVID-19 and Health Disparities
NIDDK Director Dr. Griffin Rodgers talks COVID-19, disparities in health, and top priorities at the institute.
-
Dr. Griffin Rodgers Director NIDDK
Related Content
-
NOAA Secures the Seas with AI and Autonomy
Rear Adm. Chad Cary says his agency integrates emerging technology and systems to enhance marine domain awareness.
10m watch -
CMMC Needs to Adapt to Evolving Cyber Threats
Katie Arrington says DOD needs to strengthen dynamic cybersecurity in the age of AI and quantum.
13m listen -
VA Secretary Tells Congress Tech Efficiencies Will Help Offset Workforce Reductions
Technology improvements will help allow department to maintain veteran care, VA leadership tells Senate Veterans Affairs Committee.
-
Navy Lab's PROTEUS Provides AI-Powered Maritime Awareness
NRL's Alan Hope details how real-time data and AI are empowering agencies to track vessels, combat threats and enhance maritime domain awareness.
23m watch
